Independent Director · ENANTA PHARMACEUTICALS INC (ENTA)

Chair, Compensation Committee

Kristine Peterson — ENANTA PHARMACEUTICALS Director Compensation (2025)

Fiscal year 2025 director compensation for Kristine Peterson at ENANTA PHARMACEUTICALS INC. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed January 26, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Kristine Peterson’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Kristine Peterson and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

ENANTA PHARMACEUTICALS Director Compensation Table · all 3 fiscal years held
In US dollars, as ENANTA PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$70,000$0$61,332$0$131,332
FY2024$70,000—$256,406—$326,406
FY2023$70,000—$256,406$0$326,406

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ENANTA PHARMACEUTICALS INC DEF 14A filed January 26, 2026, accession 0001193125-26-022558, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ENANTA PHARMACEUTICALS INC filed document, accession 0001193125-26-022558. Every figure is read from that document and cited to the page and table it appears in. Filed January 26, 2026.

Get the ENANTA PHARMACEUTICALS Board Governance Report

$131,332 Kristine Peterson, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of January 26, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

ENANTA PHARMACEUTICALS pays directors a $50,000 cash retainer and $61,332 in Stock Options.

Committees

FY2025 · as the proxy prints them

Compensation (Chair) · Nominating/Governance

The rest of the ENANTA PHARMACEUTICALS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Bruce L.A. Carter, Ph.DChair of the Board$158,832
Jay R. Luly, Ph.DDirector—
Lesley Russell, MBChB, MRCPIndependent Director$126,332
Mark G. FolettaIndependent Director$136,332
Terry C. VanceIndependent Director$138,832
Yujiro HataIndependent Director$123,832

The full ENANTA PHARMACEUTICALS compensation record

free company brief

This page is one director within ENANTA PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the ENANTA PHARMACEUTICALS proxy · each links to its own free brief

Order ENTA

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report